These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 16135587

  • 21. A randomised controlled trial of metronidazole for the prevention of preterm birth in women positive for cervicovaginal fetal fibronectin: the PREMET Study.
    Shennan A, Crawshaw S, Briley A, Hawken J, Seed P, Jones G, Poston L.
    BJOG; 2006 Jan; 113(1):65-74. PubMed ID: 16398774
    [Abstract] [Full Text] [Related]

  • 22. Prevention of preterm birth with vaginal progesterone or 17-alpha-hydroxyprogesterone caproate: a critical examination of efficacy and safety.
    O'Brien JM, Lewis DF.
    Am J Obstet Gynecol; 2016 Jan; 214(1):45-56. PubMed ID: 26558340
    [Abstract] [Full Text] [Related]

  • 23. Prevention of preterm delivery after successful tocolysis in preterm labor by 17 alpha-hydroxyprogesterone caproate: a randomized controlled trial.
    Rozenberg P, Chauveaud A, Deruelle P, Capelle M, Winer N, Desbrière R, Perrotin F, Bohec C, Connan L, Vayssière C, Langer B, Mantel A, Azimi S, Porcher R, Azria E, Groupe De Recherche En Obstétrique et Gynécologie.
    Am J Obstet Gynecol; 2012 Mar; 206(3):206.e1-9. PubMed ID: 22381603
    [Abstract] [Full Text] [Related]

  • 24. Increased incidence of gestational diabetes in women receiving prophylactic 17alpha-hydroxyprogesterone caproate for prevention of recurrent preterm delivery.
    Rebarber A, Istwan NB, Russo-Stieglitz K, Cleary-Goldman J, Rhea DJ, Stanziano GJ, Saltzman DH.
    Diabetes Care; 2007 Sep; 30(9):2277-80. PubMed ID: 17563346
    [Abstract] [Full Text] [Related]

  • 25. Association of 17α-Hydroxyprogesterone Caproate and Risk of Infection.
    Mainiero AD, Rouse DJ, Lopes V, Hughes BL.
    Obstet Gynecol; 2015 Jul; 126(1):103-8. PubMed ID: 26241262
    [Abstract] [Full Text] [Related]

  • 26. The use of progestational agents for preterm birth: lessons from a mouse model.
    Elovitz MA, Mrinalini C.
    Am J Obstet Gynecol; 2006 Oct; 195(4):1004-10. PubMed ID: 17000233
    [Abstract] [Full Text] [Related]

  • 27. Vaginal progesterone is associated with a decrease in risk for early preterm birth and improved neonatal outcome in women with a short cervix: a secondary analysis from a randomized, double-blind, placebo-controlled trial.
    DeFranco EA, O'Brien JM, Adair CD, Lewis DF, Hall DR, Fusey S, Soma-Pillay P, Porter K, How H, Schakis R, Eller D, Trivedi Y, Vanburen G, Khandelwal M, Trofatter K, Vidyadhari D, Vijayaraghavan J, Weeks J, Dattel B, Newton E, Chazotte C, Valenzuela G, Calda P, Bsharat M, Creasy GW.
    Ultrasound Obstet Gynecol; 2007 Oct; 30(5):697-705. PubMed ID: 17899571
    [Abstract] [Full Text] [Related]

  • 28. Women receiving 17-alpha-hydroxyprogesterone caproate hospitalized for preterm labor at less than 34 weeks benefit from daily perinatal nursing surveillance.
    Rittenberg C, Sullivan S, Istwan N, Rhea D, Stanziano G, Newman R.
    Am J Obstet Gynecol; 2008 Oct; 199(4):389.e1-4. PubMed ID: 18928983
    [Abstract] [Full Text] [Related]

  • 29. Vaginal progesterone vs intramuscular 17-hydroxyprogesterone caproate for prevention of recurrent preterm birth: a randomized controlled trial.
    Boelig RC, Schoen CN, Frey H, Gimovsky AC, Springel E, Backley S, Berghella V.
    Am J Obstet Gynecol; 2022 May; 226(5):722.e1-722.e12. PubMed ID: 35189093
    [Abstract] [Full Text] [Related]

  • 30. 17-alpha hydroxyprogesterone caproate for preterm birth prevention: Where have we been, how did we get here, and where are we going?
    Manuck TA.
    Semin Perinatol; 2017 Dec; 41(8):461-467. PubMed ID: 28947068
    [Abstract] [Full Text] [Related]

  • 31. Outcomes With Cerclage Alone Compared With Cerclage Plus 17α-Hydroxyprogesterone Caproate.
    Stetson B, Hibbard JU, Wilkins I, Leftwich H.
    Obstet Gynecol; 2016 Nov; 128(5):983-988. PubMed ID: 27741201
    [Abstract] [Full Text] [Related]

  • 32. Placental histology for targeted risk assessment of recurrent spontaneous preterm birth.
    Suresh S, Freedman A, Adams M, Hirsch E, Ernst LM.
    Am J Obstet Gynecol; 2024 Apr; 230(4):452.e1-452.e11. PubMed ID: 37751829
    [Abstract] [Full Text] [Related]

  • 33. 17α Hydroxyprogesterone caproate for prevention of recurrent spontaneous preterm birth.
    Merlob P, Stahl B, Klinger G.
    Reprod Toxicol; 2012 Jan; 33(1):15-9. PubMed ID: 22120850
    [Abstract] [Full Text] [Related]

  • 34. High-risk prematurity--progestin treatment and steroid studies.
    Johnson JW, Lee PA, Zachary AS, Calhoun S, Migeon CJ.
    Obstet Gynecol; 1979 Oct; 54(4):412-8. PubMed ID: 492618
    [Abstract] [Full Text] [Related]

  • 35. Influence of gestational age and reason for prior preterm birth on rates of recurrent preterm delivery.
    Gonzalez-Quintero VH, Cordova YC, Istwan NB, Tudela F, Rhea DJ, Romary LM, Marimon A, Desch CN, Stanziano GJ.
    Am J Obstet Gynecol; 2011 Sep; 205(3):275.e1-5. PubMed ID: 22071063
    [Abstract] [Full Text] [Related]

  • 36. Progestogens for Maintenance Tocolysis in Women With a Short Cervix: A Randomized Controlled Trial.
    Facchinetti F, Vergani P, Di Tommaso M, Marozio L, Acaia B, Vicini R, Pignatti L, Locatelli A, Spitaleri M, Benedetto C, Zaina B, DʼAmico R.
    Obstet Gynecol; 2017 Jul; 130(1):64-70. PubMed ID: 28594783
    [Abstract] [Full Text] [Related]

  • 37. 17α-hydroxyprogesterone caproate for the prevention of adverse neonatal outcome in multiple pregnancies: a randomized controlled trial.
    Lim AC, Schuit E, Bloemenkamp K, Bernardus RE, Duvekot JJ, Erwich JJHM, van Eyck J, Groenwold RHH, Hasaart THM, Hummel P, Kars MM, Kwee A, van Oirschot CM, van Pampus MG, Papatsonis D, Porath MM, Spaanderman ME, Willekes C, Wilpshaar J, Mol BWJ, Bruinse HW.
    Obstet Gynecol; 2011 Sep; 118(3):513-520. PubMed ID: 21860279
    [Abstract] [Full Text] [Related]

  • 38. 17-alpha Hydroxyprogesterone caproate did not reduce the rate of recurrent preterm birth in a prospective cohort study.
    Nelson DB, McIntire DD, McDonald J, Gard J, Turrichi P, Leveno KJ.
    Am J Obstet Gynecol; 2017 Jun; 216(6):600.e1-600.e9. PubMed ID: 28223163
    [Abstract] [Full Text] [Related]

  • 39. [Prevention of preterm delivery with gestagens].
    Schindler AE.
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):165-9. PubMed ID: 15508049
    [Abstract] [Full Text] [Related]

  • 40. The rebirth of progesterone in the prevention of preterm labor.
    Schmouder VM, Prescott GM, Franco A, Fan-Havard P.
    Ann Pharmacother; 2013 Apr; 47(4):527-36. PubMed ID: 23535817
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.